Manchester Capital Management’s Acceleron Pharma XLRN Stock Holding History

Manchester Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,236	Closed	-$213K	–	1139
2021 Q3	$213K	Sell	1,236 -11	-0.9%	-$1.44K	0.03%	269
2021 Q2	$156K	Buy	1,247 +10	+0.8%	+$1.26K	0.02%	286
2021 Q1	$168K	Hold	1,237	–	–	0.03%	275
2020 Q4	$158K	Hold	1,237	–	–	0.02%	262
2020 Q3	$139K	Buy	+1,237	New	+$123K	0.02%	249
2019 Q2	–	Sell	-520	Closed	-$24K	–	666
2019 Q1	$24K	Buy	+520	New	+$22.8K	﹤0.01%	502

Manchester Capital Management's XLRN Position: Q4 2021 in Review

Manchester Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,236 shares — an estimated $213K sold.

Manchester Capital Management first reported a position in XLRN in Q1 2019 and held it in 6 quarters. The position peaked at $213K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Manchester Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Manchester Capital Management sold 1,236 Acceleron Pharma shares in Q4 2021, an estimated $213K.
Manchester Capital Management first reported a position in Acceleron Pharma in Q1 2019 and held it in 6 quarters.
Manchester Capital Management's Acceleron Pharma position peaked at $213K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Manchester Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.